Global Preclinical Imaging Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Preclinical Imaging Market:
Global preclinical imaging market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for preclinical imaging is projected to reach US$ XX Mn by 2023.
Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others.
Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the preclinical imaging market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market.
The preclinical imaging market has been segmented by type of product, application, and end-user
Based on product type, preclinical imaging market segmented as:
Geographically, global preclinical imaging market is segmented into Europe, North America, Latin America, Asia Pacific, and Middle East & Africa., North America expected to grow at significant rates due to increase in adoption of new technologies for better clinical outputs, technological advancements, and growing prevalence rates chronic diseases such as cardiovascular disease, cancer. According to the National Cancer Institute, in 2017, about 1,685,210 new cancer cases are expected to be diagnosed. Europe is expected to be another major market for preclinical imaging owing to factors such as increase in healthcare awareness among people and research and development activity for treating and preventing diseases. Asia-Pacific preclinical imaging market expected to show lucrative growth opportunity owing to cost-effective clinical and preclinical imaging services, coupled with favourable government policies.
Major players operating in preclinical imaging market include FUJIFILM Holdings Corporation (Japan), MR Solutions (U.K.), PerkinElmer Inc. (U.S.), Siemens Ltd (U.S.), Miltenyi Biotec (Germany), Aspect Imaging (Canada), MILabs B.V. (Netherlands), Bruker Corporation (U.S.), Mediso Ltd. (Hungary), TriFoil Imaging (U.S.), and Carestream Health (U.S.) to name a few.
In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio
In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector
In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russia’s first 3D Optical imaging system at Novosibirsk
REPORT OUTLINE:
Global preclinical imaging market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for preclinical imaging is projected to reach US$ XX Mn by 2023.
Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others.
Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the preclinical imaging market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market.
The preclinical imaging market has been segmented by type of product, application, and end-user
Based on product type, preclinical imaging market segmented as:
- Imaging Modalities
- Single Photon emission computed tomography (SPECT)
- Micro Computed Tomography (Micro-CT)
- Magnetic Particle Imaging
- Magnetic Resonance Imaging (MRI)
- Optical Imaging
- X-Ray Imaging
- Positron Emission Tomography (PET)
- Ultrasound
- Others
- Reagents and Kits
- Research and Development
- Drug Discovery
- Biotech Companies
- Pharmaceutical companies
- Research institutes
Geographically, global preclinical imaging market is segmented into Europe, North America, Latin America, Asia Pacific, and Middle East & Africa., North America expected to grow at significant rates due to increase in adoption of new technologies for better clinical outputs, technological advancements, and growing prevalence rates chronic diseases such as cardiovascular disease, cancer. According to the National Cancer Institute, in 2017, about 1,685,210 new cancer cases are expected to be diagnosed. Europe is expected to be another major market for preclinical imaging owing to factors such as increase in healthcare awareness among people and research and development activity for treating and preventing diseases. Asia-Pacific preclinical imaging market expected to show lucrative growth opportunity owing to cost-effective clinical and preclinical imaging services, coupled with favourable government policies.
Major players operating in preclinical imaging market include FUJIFILM Holdings Corporation (Japan), MR Solutions (U.K.), PerkinElmer Inc. (U.S.), Siemens Ltd (U.S.), Miltenyi Biotec (Germany), Aspect Imaging (Canada), MILabs B.V. (Netherlands), Bruker Corporation (U.S.), Mediso Ltd. (Hungary), TriFoil Imaging (U.S.), and Carestream Health (U.S.) to name a few.
In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio
In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector
In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russia’s first 3D Optical imaging system at Novosibirsk
REPORT OUTLINE:
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL PRECLINICAL IMAGING MARKET INTRODUCTION
2.1. Global Preclinical Imaging Market – Taxonomy
2.2. Global Preclinical Imaging Market –Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End-User
3. GLOBAL PRECLINICAL IMAGING MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Preclinical Imaging Market Dynamics – Factors Impact Analysis
3.6. Global Preclinical Imaging Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Preclinical Imaging Market – Recent Product Innovations
4. GLOBAL PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Imaging Modalities
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Single Photon Emission Computed Tomography (SPECT)
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Micro Computed Tomography (Micro-CT)
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Magnetic Particle Imaging
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Magnetic Resonance Imaging (MRI)
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Optical Imaging
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. X-Ray Imaging
5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Positron Emission Tomography (PET)
5.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Ultrasound
5.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Others
5.10.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
5.11. Reagents and Kits
5.11.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.11.3. Market Opportunity Analysis
5.12. Others
5.12.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.12.3. Market Opportunity Analysis
6. GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Researcha and Development
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Drug Discovery
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. GLOBAL PRECLINICAL IMAGING MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Biotechnology Companies
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pharma Companies
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Research Institutes
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL PRECLINICAL IMAGING MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-Use and Region, 2017 – 2023
9. NORTH AMERICA PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Imaging Modalities
9.1.1.2. Single Photon emission computed tomography (SPECT)
9.1.1.3. Micro Computed Tomography (Micro-CT)
9.1.1.4. Magnetic Particle Imaging
9.1.1.5. Magnetic Resonance Imaging (MRI)
9.1.1.6. Optical Imaging
9.1.1.7. X-Ray Imaging
9.1.1.8. Positron Emission Tomography (PET)
9.1.1.9. Ultrasound
9.1.1.10. Others
9.1.1.11. Reagents and Kits
9.1.1.12. Others
9.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Research and Development
9.1.2.2. Drug Discovery
9.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Biotech Companies
9.1.3.2. Pharmaceutical Companies
9.1.3.3. Research Institutes
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-Use and Country, 2017 – 2023
9.1.6. North America Preclinical Imaging Market Dynamics – Trends
10. EUROPE PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Imaging Modalities
10.1.1.2. Single Photon emission computed tomography (SPECT)
10.1.1.3. Micro Computed Tomography (Micro-CT)
10.1.1.4. Magnetic Particle Imaging
10.1.1.5. Magnetic Resonance Imaging (MRI)
10.1.1.6. Optical Imaging
10.1.1.7. X-Ray Imaging
10.1.1.8. Positron Emission Tomography (PET)
10.1.1.9. Ultrasound
10.1.1.10. Others
10.1.1.11. Reagents and Kits
10.1.1.12. Others
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Research and Development
10.1.2.2. Drug Discovery
10.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Biotech Companies
10.1.3.2. Pharmaceutical Companies
10.1.3.3. Research Institutes
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
10.1.6. Europe Preclinical Imaging Market Dynamics – Trends
11. ASIA-PACIFIC PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Imaging Modalities
11.1.1.2. Single Photon emission computed tomography (SPECT)
11.1.1.3. Micro Computed Tomography (Micro-CT)
11.1.1.4. Magnetic Particle Imaging
11.1.1.5. Magnetic Resonance Imaging (MRI)
11.1.1.6. Optical Imaging
11.1.1.7. X-Ray Imaging
11.1.1.8. Positron Emission Tomography (PET)
11.1.1.9. Ultrasound
11.1.1.10. Others
11.1.1.11. Reagents and Kits
11.1.1.12. Others
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Research and Development
11.1.2.2. Drug Discovery
11.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Biotech Companies
11.1.3.2. Pharmaceutical Companies
11.1.3.3. Research Institutes
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 – 2023
11.1.6. Asia-Pacific Preclinical Imaging Market Dynamics – Trends
12. LATIN AMERICA PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Imaging Modalities
12.1.1.2. Single Photon emission computed tomography (SPECT)
12.1.1.3. Micro Computed Tomography (Micro-CT)
12.1.1.4. Magnetic Particle Imaging
12.1.1.5. Magnetic Resonance Imaging (MRI)
12.1.1.6. Optical Imaging
12.1.1.7. X-Ray Imaging
12.1.1.8. Positron Emission Tomography (PET)
12.1.1.9. Ultrasound
12.1.1.10. Others
12.1.1.11. Reagents and Kits
12.1.1.12. Others
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Research and Development
12.1.2.2. Drug Discovery
12.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Biotech Companies
12.1.3.2. Pharmaceutical Companies
12.1.3.3. Research Institutes
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 – 2023
12.1.6. Latin America Preclinical Imaging Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Imaging Modalities
13.1.1.2. Single Photon emission computed tomography (SPECT)
13.1.1.3. Micro Computed Tomography (Micro-CT)
13.1.1.4. Magnetic Particle Imaging
13.1.1.5. Magnetic Resonance Imaging (MRI)
13.1.1.6. Optical Imaging
13.1.1.7. X-Ray Imaging
13.1.1.8. Positron Emission Tomography (PET)
13.1.1.9. Ultrasound
13.1.1.10. Others
13.1.1.11. Reagents and Kits
13.1.1.12. Others
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Research and Development
13.1.2.2. Drug Discovery
13.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Biotech Companies
13.1.3.2. Pharmaceutical Companies
13.1.3.3. Research Institutes
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 – 2023
13.1.6. MEA Preclinical Imaging Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. FUJIFILM Holdings Corporation (Japan)
14.2.2. MR Solutions (U.K.)
14.2.3. PerkinElmer Inc. (U.S.)
14.2.4. Siemens Ltd (U.S.)
14.2.5. Miltenyi Biotec (Germany)
14.2.6. Aspect Imaging (Canada)
14.2.7. MILabs B.V. (Netherlands)
14.2.8. Bruker Corporation (U.S.)
14.2.9. Mediso Ltd. (Hungary)
14.2.10. TriFoil Imaging (U.S.)
14.2.11. Carestream Health (U.S.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL PRECLINICAL IMAGING MARKET INTRODUCTION
2.1. Global Preclinical Imaging Market – Taxonomy
2.2. Global Preclinical Imaging Market –Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End-User
3. GLOBAL PRECLINICAL IMAGING MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Preclinical Imaging Market Dynamics – Factors Impact Analysis
3.6. Global Preclinical Imaging Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Preclinical Imaging Market – Recent Product Innovations
4. GLOBAL PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Imaging Modalities
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Single Photon Emission Computed Tomography (SPECT)
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Micro Computed Tomography (Micro-CT)
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Magnetic Particle Imaging
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Magnetic Resonance Imaging (MRI)
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Optical Imaging
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. X-Ray Imaging
5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Positron Emission Tomography (PET)
5.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Ultrasound
5.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Others
5.10.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
5.11. Reagents and Kits
5.11.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.11.3. Market Opportunity Analysis
5.12. Others
5.12.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.12.3. Market Opportunity Analysis
6. GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Researcha and Development
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Drug Discovery
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. GLOBAL PRECLINICAL IMAGING MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Biotechnology Companies
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pharma Companies
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Research Institutes
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL PRECLINICAL IMAGING MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-Use and Region, 2017 – 2023
9. NORTH AMERICA PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Imaging Modalities
9.1.1.2. Single Photon emission computed tomography (SPECT)
9.1.1.3. Micro Computed Tomography (Micro-CT)
9.1.1.4. Magnetic Particle Imaging
9.1.1.5. Magnetic Resonance Imaging (MRI)
9.1.1.6. Optical Imaging
9.1.1.7. X-Ray Imaging
9.1.1.8. Positron Emission Tomography (PET)
9.1.1.9. Ultrasound
9.1.1.10. Others
9.1.1.11. Reagents and Kits
9.1.1.12. Others
9.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Research and Development
9.1.2.2. Drug Discovery
9.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Biotech Companies
9.1.3.2. Pharmaceutical Companies
9.1.3.3. Research Institutes
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-Use and Country, 2017 – 2023
9.1.6. North America Preclinical Imaging Market Dynamics – Trends
10. EUROPE PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Imaging Modalities
10.1.1.2. Single Photon emission computed tomography (SPECT)
10.1.1.3. Micro Computed Tomography (Micro-CT)
10.1.1.4. Magnetic Particle Imaging
10.1.1.5. Magnetic Resonance Imaging (MRI)
10.1.1.6. Optical Imaging
10.1.1.7. X-Ray Imaging
10.1.1.8. Positron Emission Tomography (PET)
10.1.1.9. Ultrasound
10.1.1.10. Others
10.1.1.11. Reagents and Kits
10.1.1.12. Others
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Research and Development
10.1.2.2. Drug Discovery
10.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Biotech Companies
10.1.3.2. Pharmaceutical Companies
10.1.3.3. Research Institutes
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
10.1.6. Europe Preclinical Imaging Market Dynamics – Trends
11. ASIA-PACIFIC PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Imaging Modalities
11.1.1.2. Single Photon emission computed tomography (SPECT)
11.1.1.3. Micro Computed Tomography (Micro-CT)
11.1.1.4. Magnetic Particle Imaging
11.1.1.5. Magnetic Resonance Imaging (MRI)
11.1.1.6. Optical Imaging
11.1.1.7. X-Ray Imaging
11.1.1.8. Positron Emission Tomography (PET)
11.1.1.9. Ultrasound
11.1.1.10. Others
11.1.1.11. Reagents and Kits
11.1.1.12. Others
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Research and Development
11.1.2.2. Drug Discovery
11.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Biotech Companies
11.1.3.2. Pharmaceutical Companies
11.1.3.3. Research Institutes
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 – 2023
11.1.6. Asia-Pacific Preclinical Imaging Market Dynamics – Trends
12. LATIN AMERICA PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Imaging Modalities
12.1.1.2. Single Photon emission computed tomography (SPECT)
12.1.1.3. Micro Computed Tomography (Micro-CT)
12.1.1.4. Magnetic Particle Imaging
12.1.1.5. Magnetic Resonance Imaging (MRI)
12.1.1.6. Optical Imaging
12.1.1.7. X-Ray Imaging
12.1.1.8. Positron Emission Tomography (PET)
12.1.1.9. Ultrasound
12.1.1.10. Others
12.1.1.11. Reagents and Kits
12.1.1.12. Others
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Research and Development
12.1.2.2. Drug Discovery
12.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Biotech Companies
12.1.3.2. Pharmaceutical Companies
12.1.3.3. Research Institutes
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 – 2023
12.1.6. Latin America Preclinical Imaging Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Imaging Modalities
13.1.1.2. Single Photon emission computed tomography (SPECT)
13.1.1.3. Micro Computed Tomography (Micro-CT)
13.1.1.4. Magnetic Particle Imaging
13.1.1.5. Magnetic Resonance Imaging (MRI)
13.1.1.6. Optical Imaging
13.1.1.7. X-Ray Imaging
13.1.1.8. Positron Emission Tomography (PET)
13.1.1.9. Ultrasound
13.1.1.10. Others
13.1.1.11. Reagents and Kits
13.1.1.12. Others
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Research and Development
13.1.2.2. Drug Discovery
13.1.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Biotech Companies
13.1.3.2. Pharmaceutical Companies
13.1.3.3. Research Institutes
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Preclinical Imaging Market - Opportunity Analysis Index, By Product Type, Application, End-User and Country, 2017 – 2023
13.1.6. MEA Preclinical Imaging Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. FUJIFILM Holdings Corporation (Japan)
14.2.2. MR Solutions (U.K.)
14.2.3. PerkinElmer Inc. (U.S.)
14.2.4. Siemens Ltd (U.S.)
14.2.5. Miltenyi Biotec (Germany)
14.2.6. Aspect Imaging (Canada)
14.2.7. MILabs B.V. (Netherlands)
14.2.8. Bruker Corporation (U.S.)
14.2.9. Mediso Ltd. (Hungary)
14.2.10. TriFoil Imaging (U.S.)
14.2.11. Carestream Health (U.S.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
